Clinical Trial Update: Durvalumab and Standard Chemotherapy Before Surgery in Treating Patients With Variant Histology Bladder Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating durvalumab in combination with standard chemotherapy before surgery for variant histology bladder cancers; study terminated with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of Bladder
• Bladder Cancer
• Bladder Squamous Cell Carcinoma
• Bladder Urothelial Carcinoma

Drugs mentioned

• Durvalumab (durvalumab)
• Durvalumab and standard chemotherapy

Snippet

Sponsor: Stanford University | Conditions: Bladder Adenocarcinoma, Bladder Mixed Adenocarcinoma | Phase 2 | Status: TERMINATED | Results posted: 2023-09-11